The National Health Surveillance Agency (Anvisa) has granted a new sanitary authorization for another Cannabis-based product in the Brazilian market. The decision formalizes the permission for Cannten LTDA. to commercialize its Cannabis Sativa Extract.

The measure was published in the Official Gazette through Resolution-RE No. 3,782, dated September 25, 2025. The authorized extract has a concentration of 71.33 mg/mL and, like others, falls within the guidelines of RDC 327/2019, which regulates the commercialization of such products for medicinal purposes.

The authorization is specific to the formula with a tetrahydrocannabinol (THC) content of up to 0.2%. The product will be presented in drop solution form, in a 30 ml bottle accompanied by a dropper for administration.